LM FUNDING AMERICA, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LM FUNDING AMERICA, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.84M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.00M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $12.98M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.73M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $898.9K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.26M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.39M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.39M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.39M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $4.90M | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($26.92M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($7.32M) | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | ($4.28M) | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | ($5.61M) | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | $1.94M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($15.94M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($29.24M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.76M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.04M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($3.00M) | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.88M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($6.46M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($10.07M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($24.68M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($8.43M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.05M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.98M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($412.3K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($3.47M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($3.09M) | Apr 17, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $817.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $851.8K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $635.3K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $418.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $351.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $203.2K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $323.0K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $810.3K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.08M | Apr 17, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.99M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($11.95M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.40M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($9.14M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.70M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.52M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($1.16M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($758.3K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.81M) | Apr 16, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.21M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.73M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.63M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $15.4K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $14.4K | Mar 31, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.32M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $44.05M | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | $37.86M | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | $35.05M | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | $40.61M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $37.71M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $53.19M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $62.10M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $12.32M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $7.64M | Mar 31, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.44M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $8.70M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.85M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.39M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.09M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $849.1K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.81M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $250.9K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $1.07M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $5.85M | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.62M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $37.03M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $36.19M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $49.19M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $60.76M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.46M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.83M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $5.81M | Apr 14, 2020 |
| FY2019 | Dec 31, 2017 | $897.0K | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | $4.17M | Apr 16, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $4.04M | Mar 31, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($92.58M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($65.66M) | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | ($66.30M) | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | ($62.02M) | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | ($56.41M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($58.96M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($43.02M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($13.78M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.54M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($14.49M) | Mar 31, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $32.56M | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $11.55M | Mar 31, 2022 |
| FY2021 | Dec 31, 2019 | $1.07M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $3.52M | Mar 31, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $185.8K | Mar 31, 2022 |
| FY2019 | Dec 31, 2019 | $517.6K | Apr 14, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (6) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | (2) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | (25) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 17, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (6) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | (2) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | (25) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 17, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.12M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 5.13M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 2.49M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 2.23M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 13.02M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 3.08M | Mar 31, 2022 |
| FY2021 | May 11, 2020 | 5.41M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 3.13M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 3.12M | Apr 14, 2020 |
| FY2019 | Oct 16, 2018 | 625,318 | Apr 14, 2020 |